Pharmacodynamic model for chemoradiotherapy-induced thrombocytopenia in mice

Journal of Pharmacokinetics and Pharmacodynamics
Wojciech KrzyzanskiJohn Harrold

Abstract

A mechanistic model describing the effects of chemotherapy and radiation on platelet counts and endogenous thrombopoietin (eTPO) in mice was developed. Thrombocytopenia was induced in mice by injection of carboplatin followed by the whole body irradiation on days 0, 28, and 56, with platelet and eTPO samples collected over 84 days. The pharmacodynamic model consisted of a series of aging compartments representing proliferating megakaryocyte precursors, megakaryocytes, and platelets with possible eTPO clearance through internalization. The cytotoxic effects of treatment were described by the kinetics of the effect (K-PD) model, and stimulation of platelet production by eTPO was considered to be driven by receptor occupancy. The proposed PD model adequately described the platelet counts and eTPO concentrations in mice by accounting for nadirs and peaks of platelet count, and rebounds in eTPO time course profiles. The estimates of model parameters were in good agreement with their physiological values reported in literature for mice with platelet lifespan of 4.3 days and 185 cMpl receptors per platelet. The predicted duration of the treatment effect was 0.82 h (approximately 5 carboplatin half-lives in mice). The data was not info...Continue Reading

References

May 8, 1999·British Journal of Haematology·C YangD J Kuter
Dec 19, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lena E FribergMats O Karlsson
Jan 10, 2003·Journal of Pharmacokinetics and Pharmacodynamics·Wojciech Krzyzanski, William J Jusko
Jan 1, 1961·Proceedings of the Society for Experimental Biology and Medicine·T T ODELL, T P McDONALD
Jan 1, 1955·Quarterly Journal of Experimental Physiology and Cognate Medical Sciences·J H GADDUMF F STEPHENS
Sep 24, 2005·Pharmaceutical Research·Donald E Mager, Wojciech Krzyzanski
Apr 10, 2007·Critical Reviews in Oncology/hematology·Diane Testart-PailletBrigitte Tranchand
Sep 25, 2007·Cancer Chemotherapy and Pharmacology·Sukyung WooWilliam J Jusko
Jul 31, 2009·Annual Review of Medicine·David J Kuter
Dec 15, 2011·Journal of Clinical Pharmacology·J J Perez-RuixoD R Mould
Aug 29, 2012·Journal of Pharmacokinetics and Pharmacodynamics·Xiaoyu YanWojciech Krzyzanski
Nov 23, 2012·British Journal of Clinical Pharmacology·Juan Jose Perez RuixoDiane R Mould
Dec 20, 2012·Pharmaceutical Research·Wojciech KrzyzanskiYow-Ming Wang
Apr 9, 2013·Cancer Chemotherapy and Pharmacology·Siobhan HayesEkaterina Gibiansky
Jun 27, 2013·Pharmaceutical Research·Mélanie L PastorDidier Concordet
Jul 23, 2014·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Shinji KobuchiToshiyuki Sakaeda

❮ Previous
Next ❯

Citations

Dec 28, 2018·Pharmacological Reviews·Johan GabrielssonStephan Hjorth
Oct 9, 2021·Journal of Pharmacokinetics and Pharmacodynamics·Tim CardilinJohan Gabrielsson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.